top of page

Publications
Carper, M.B., Selitsky, S.R., Troutman, S., Wagner, B., Byrd, K.M., Sharma,K.P., Henry, E.C., Li, W., Parker, J., Montgomery, S.A., Cleveland, J.L., Williams, S.E., Kissil, J.L., Hayes, D.N. and Amelio, A.L. “An Immunocompetent Mouse Model of HPV16(+) Head and Neck Squamous Cell Carcinoma”. Cell reports, 29;1660-1674, 2019.
Kota, S., Hou, S., Guerrant, W., Madoux, F., Troutman, S., Fernandez-Vega, V., Alekseeva, N., Madala, N., Scampavia, L., Kissil, J.L.# and Spicer, T.P.# (#corresponding authors). “A novel 3-dimenasional high throughput screening approach identifies inducers of a KRAS selective lethal phenotype”. Oncogene 37;4372-4384, 2018.
Guerrant, W., Kota, S., Troutman, S., Mandati, V., Fallahi, M., Stemmer-Rachamimov, A. and Kissil, J.L. “YAP mediates tumorigenesis in neurofibromatosis type 2 by promoting cell survival through a COX2-EGFR signaling axis”. Cancer Research. 76(12):3507-19, 2016
Yi, C., Shen, Z., Stemmer-Rachamimov, A., Dawany, N., Troutman, S., Showe, L.C., Liu, Q., Shimono, A., Sudol, M., Holmgren, L., Stanger, B.Z. and Kissil, J.L. “Angiomotin-p130 is required for Yap-mediated hepatic epithelial cell expansion and tumorigenesis”. Science Signaling. 6:ra77, 2013.
Licciulli, S., Maximoska, J., Zhou, C., Troutman, S., Kota, S., Liu, Q., Duron, S., Campbell, D., Chernoff, J., Field, J., Marmorstein, R. and Kissil, J.L. “FRAX597, a small molecule inhibitor of the p21-activated kinases, inhibits tumorigenesis of NF2-associated schwannomas”. J Biol Chem. 288(40):29105-14, 2013.
Yi, C., Troutman, S., Fera, D., Stemmer-Rachamimov, A., Avila, J., Christian, N., Persson, N.L., Speicher, D.W., Shimono, A., Marmorstein, R., Holmgren, L. and Kissil, J.L. “A Tight Junction-Associated Merlin-Angiomotin Complex Mediates Merlin’s Regulation of Mitogenic Signaling and Tumor Suppressive Functions”. Cancer Cell. 19:527-540, 2011
bottom of page